Susan J. Boorin, PhD, MSN, PMHNP-BC
Susan J. Boorin, PhD, MSN, PMHNP-BC is a psychiatric nurse practitioner and a graduate of Yale School of Nursing’s PhD program. She is a lecturer in the Psychiatric Mental Health Nurse Practitioner Specialty at Yale, and teaches psychopharmacology, psychopathology, mental health assessment and clinical seminar in the first year specialty program.
Dr. Boorin received her master’s degree from Hunter College of the City University of NY where she received the Dean’s Award for Outstanding Graduate Student and was the 1992 class commencement speaker. Dr. Boorin continued her education with a post-master’s degree from Yale School of Nursing and then earned her PhD from Yale in 2013 where she received the Anthony DiGuida Delta Mu Research prize in nursing.
Dr. Boorin has worked in both outpatient and inpatient mental health services in New York and Connecticut over the past several decades; with clinical experiences ranging from work in acute psychiatric ICU units to community outpatient settings. Dr. Boorin is the owner of a nurse owned small business on the Milford Green, Psychiatric Health Associates, LLC which she established in 2014. It provides outpatient psychiatric services for individuals across the lifespan, with a practice philosophy that the therapeutic alliance between the patient and the provider is the catalyst of change.
Dr. Boorin’s research interest has focused on the mental health of children. Her master’s degree thesis from Hunter was entitled ‘The relationship of self-esteem and locus of control for the hospitalized child psychiatric client” where she received the Shuster Award for Outstanding Thesis. During her training for her PhD at Yale, she worked on research projects at Yale Child Study Center involving children with a diagnosis of autism, parent training, psychopharmacology, and cardiometabolic monitoring for children treated with psychiatric medication. Her dissertation is entitled ‘Cardiometabolic Side Effects of Risperidone in Children with Autism’.
Boorin, S. & Keltner, N. (publication 2020). Neurobiology and neurophysiology of behavioral/psychiatric disorders. In Yearwood, E.L., Pearson, G.S. & Newland, J.A. Child and Adolescent Behavioral Health: A Resource for Advanced Psychiatric and Primary Care Practitioners in Nursing, 2nd Ed. Wiley-Blackwell: Iowa.
Boorin, S. (2020). Antipsychotics (2nd edition). In Volkmar, F. Editor in Chief, Encyclopedia of Autism Spectrum Disorders. Springer: New York.
Scahill, L., Jeon, S., Boorin, S. J., McDougle, C. J., Aman, M. G., Dziura, J., … Vitiello, B. (2016). Weight Gain and Metabolic Consequences of Risperidone in Young Children with Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 55(5), 415-423. DOI: 10.1016/j.jaac.2016.02.016
Boorin, S. (September 14, 2012). Cardiometabolic Side Effects of Risperidone in Children with
Autism. State of the Science Congress on Nursing Research, Washington D.C.
Oral presentation of research results.
Scahill, L. & Boorin, S. (2011). Psychopharmacology in children with PDD: Review of current evidence. In Reichow, B., Doehring, P., Cicchetti, D. & Volkmar, F. (Eds.). Evidence-based practices treatments for children with autism. Springer: New York.